SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia

2001216 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Pharmacology and Experimental Therapeutics

Volume 296, Issue 2, pp. 312-321

Field-Weighted Citation Impact: 5.19